Floatz logo

Sc-Car.Gpc3Xil15.21 Car T Cells

Wilms Tumor

Seattle Children's HospitalCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

39 Active assets in the Wilms Tumor cohort.

Asset / SponsorPhaseRating
Inno-206
Children's National Research Institute
Phase 2BB
(+)-VINCRISTINE
Centre Oscar Lambret
Phase 2BB
Itraconazole
Samsung Medical Center
Phase 4BB
Irinotecan
Centre Oscar Lambret
Phase 2BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2BB

View all 50 →

Same molecule, other indications

Sc-Car.Gpc3Xil15.21 Car T Cells is also rated in:

Solid Tumor (Excluding CNS)Dormant
CC
Indicative ·
43 / 100
View asset →
liposarcomaDormant
CC
Indicative ·
43 / 100
View asset →
yolk sac tumorDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →